| Income Statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
| Revenues (includes sales to related parties of approximately 30,000, 43,000, 30,000, and 75,000, respectively) | 2,581,000 | 1,446,000 | 1,516,500* | 1,306,000 |
| Cost of revenues | 526,000 | 281,000 | 205,000* | 228,000 |
| Gross profit | 2,055,000 | 1,165,000 | 1,311,500* | 1,078,000 |
| General and administrative expenses | 2,567,000 | 2,043,000 | 1,606,500* | 3,149,000 |
| Loss from operations | -512,000 | -878,000 | -295,000* | -2,071,000 |
| Gain on sale of exotropin interests | -390,000 | NaN | NaN | NaN |
| Interest expense | 11,000 | 10,000 | 32,000* | 23,000 |
| Change in obligation to repurchase shares | NaN | NaN | 500* | NaN |
| Inducement expense to convert notes in payable | NaN | NaN | 34,000* | NaN |
| Change in obligation to repurchase shares | 17,000 | -19,000 | NaN | 0 |
| Other income | 5,000 | 17,000 | 35,000* | 22,000 |
| Net loss | -145,000 | -852,000 | -326,500 | -2,072,000 |
| Basic EPS | -0.02 | -0.12 | -0.05 | -0.32 |
| Diluted EPS | -0.02 | -0.12 | -0.05 | -0.32 |
| Basic Average Shares | 7,757,469 | 7,021,599 | 6,479,599 | 6,405,443 |
| Diluted Average Shares | 7,757,469 | 7,021,599 | 6,479,599 | 6,405,443 |
Zeo ScientifiX, Inc. (ZEOX)
Zeo ScientifiX, Inc. (ZEOX)